Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:138628.
doi: 10.1155/2011/138628. Epub 2011 Jul 18.

Titrimetric and spectrophotometric assay of oxcarbazepine in pharmaceuticals using N-bromosuccinimide and bromopyrogallol red

Affiliations

Titrimetric and spectrophotometric assay of oxcarbazepine in pharmaceuticals using N-bromosuccinimide and bromopyrogallol red

Nagaraju Rajendraprasad et al. Int J Anal Chem. 2011.

Abstract

Titrimetric and spectrophotometric methods are described for the determination of oxcarbazepine (OXC) in bulk drug and in tablets. The methods use N-bromosuccinimide (NBS) and bromopyrogallol red (BPR) as reagents. In titrimetry (method A), an acidified solution of OXC is titrated directly with NBS using methyl orange as indicator. Spectrophotometry (method B) involves the addition of known excess of NBS to an acidified solution of OXC followed by the determination of the unreacted NBS by reacting with BPR and measuring the absorbance of the unreacted dye at 460 nm. Titrimetry allows the determination of 6-18 mg of OXC and follows a reaction stoichiometry of 1 : 1 (OXC : NBS), whereas spectrophotometry is applicable over the concentration range of 0.8-8.0 μg mL(-1). Method B with a calculated molar absorptivity of 2.52 × 10(4) L mol(-1) cm(-1) is the most sensitive spectrophotometric method ever developed for OXC. The optical characteristics such as limits of detection (LOD), quantification (LOQ), and Sandell's sensitivity values are also reported for the spectrophotometric method. The accuracy and precision of the methods were studied on intraday and interday basis. The methods described could usefully be applied to routine quality control of tablets containing OXC. No interference was observed from common pharmaceutical adjuvants. Statistical comparison of the results with a reference method shows an excellent agreement and indicates no significant difference in accuracy and precision. The reliability of the methods was further ascertained by recovery studies in standard addition procedure.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Hydrolysis of NBS to produce hypobromous acid/monovalent bromine.
Scheme 2
Scheme 2
Suggested reaction pathway for the bromination of OXC.
Figure 1
Figure 1
Absorption spectra of BPR in sulphuric acid medium and the reagent blank (bromoderivative of the dye, BPR).
Figure 2
Figure 2
Study of reaction time between NBS and OXC in sulphuric acid medium and stability of the coloured species by measuring the absorbance of the unreacted BPR after reacting with NBS.
Scheme 3
Scheme 3
Tentative reaction pathway for the formation of yellow coloured bromo-derivative of BPR (method B).

References

    1. Grant SM, Faulds D. Oxcarbazepine: a review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs. 1992;43(6):873–888. - PubMed
    1. Fraser AD. New drugs for the treatment of epilepsy. Clinical Biochemistry. 1996;29(2):97–110. - PubMed
    1. Kalis MM, Huff NA. Oxcarbazepine, an antiepileptic agent. Clinical Therapeutics. 2001;23(5):680–700. - PubMed
    1. Musenga A, Saracino MA, Sani G, Raggi MA. Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoring. Current Medicinal Chemistry. 2009;16(12):1463–1481. - PubMed
    1. Juenke JM, Brown PI, Urry FM, McMillin GA. Drug monitoring and toxicology: a procedure for the monitoring of oxcarbazepine metabolite by HPLC-UV. Journal of Chromatographic Science. 2006;44(1):45–48. - PubMed

LinkOut - more resources